Scarce specialist capacity
Aseptic and injectable medicines
Where medicine cost, pharmacist time, nursing time, cleanroom capacity and treatment capacity intersect.
Question
Does this dose need making here, now, in this form?
Resource intelligence principle
Do not assume activity is waste. Connect the data, identify the signal, validate it clinically and operationally, then measure what can actually be recovered.
Observed
What we have found
- National reviews identify meaningful productivity opportunities in aseptic services.
- The true cost of a dose can include facilities, QA, cleaning, equipment and scarce capacity as well as medicine and labour.
- Ready-to-administer products, dose banding and route changes can alter the optimal pathway.
Intervention
What we would test
- Calculate true pathway cost per successfully administered dose.
- Compare local manufacture, hub supply, commercial supply and licensed ready-to-administer options.
- Detect prepared-but-unused doses, poor timing and avoidable IV activity.
- Track released aseptic and nursing capacity separately from cash savings.
Pilot measurement
What success must prove.
Observed
What actually happened?
Avoidable
Which part could plausibly have been prevented?
Recoverable
What safe intervention exists?
Verified
What changed after implementation?